A sequential injection capillary immunoassay system (SI-CI) was developed to automate the multi-step competitive bioassay procedures for hyaluronan (HA), a potential biomarker for liver and cancer diseases. Biotinylated HA-binding proteins (b-HABPs), anti-biotin conjugated with horseradish peroxidase (anti-b-HRP) and substrate 3,3′,5,5′ tetramethylbenzidene (TMB) were employed. An ordinary glass capillary was utilized as a bio-reactor where competitive assay took place. Standard HA was immobilized onto an unmodified glass capillary through simple physical adsorption. This glass capillary is much lower cost compared to a fused-silica capillary, and is well suited for use as part of the tubing of a flow system. Using the proposed system, the average amount of HA in human serums from patients with liver disease and healthy subjects could be differentiated with comparable efficiency as the conventional micro-plate assay (as compared by t-test), with an improved assay time per sample (20 min vs. 5 h), and with approximately 10 times less reagent consumption (10 -80 µl vs. 100 -350 µl).
introduction
Immunoassay and bioassay, including those that utilize specific biomolecular recognitions other than antigen-antibody pairs, [1] [2] [3] have been widely used for chemical/biochemical analysis. These techniques normally involve multi-step operational procedures that require precise timing and small reagent volume manipulation, which are highly time consuming and subjected to human errors when manually operated. Overcoming these drawbacks would be beneficial in improving such a highly specific analysis technique.
The applications of flow injection/sequential injection (FI/SI) systems in automating chemical/biochemical assays are well known, [4] [5] [6] [7] and can be adapted to use with immunoassay by changing the solid surface for the immobilization of biomolecules from the surface of a micro-plate to various forms of solid surfaces, such as bead, [8] [9] [10] membrane [11] [12] [13] and capillary. 14, 15 Beads have been widely used due to the high surface area, the ease of removal and replacement ability, and commercial availability. [16] [17] [18] However, a specially designed trapping cell, e.g. jet ring cell and Lab-on-Valve (LOV), is needed to retain beads during the incubation step. 8, 10, 18 In addition, the packed column-like feature can cause a high back pressure in the system over time. To eliminate this problem in the flow line, a capillary can be used instead. Examples of work on capillary enzyme immunoassays have been reported. These have utilized a fused-silica capillary as the solid phase, [19] [20] [21] which is expensive and only a few of these studies 14, 15 actually involve a true on-line immunoassay process.
Our ultimate goal is to develop an automatic multi-biomarkers analysis system based on sequential injection (SI) and capillary immunoassay (CI) techniques. At this stage, we are studying the condition and testing for the SI-CI system for applications of quantifying various biomarkers of interest (i.e. sialoglycoconjugates, hyaluronan, chondroitin sulfate), one at a time. Since each of these biomarkers involves different immunological biochemistries, they need to be studied separately for the optimum reagent concentrations, working range and assay time. Later, data and information will be combined to construct a SI-CI system for multi-biomarkers in one run. The information from combined biomarkers is expected to better predict a certain type or stage of disease.
We recently reported a SI-CI system for the determination of sialoglycoconjugates, a potential biomarker for cancer. 22 The reaction for the determination of sialoglycoconjugates utilized competitive binding between immobilized bovine submaxillary mucin (BSM) and sialoglycoconjugates to a limited amount of biotinylated lectin. The process was carried out in a bio-reactor, where BSM was immobilized, made of a plain glass capillary, which helped to lower the cost and to make the assay more automated.
Here, a system with similar instrumentation will be applied to the determination of another potential biomarker, called hyaluronan (HA), which requires a different immunological biochemistry than that previously reported for sialoglycoconjugates. Some of the many uses of HA include being a drug for joint disease, 23 an ingredient for cosmetics, 24 and a potential biomarker for liver, joint and cancer diseases. [25] [26] [27] In an earlier online bioassay of HA reported by our group, 8 HA was immobilized onto Sepharose beads through carbodiimide bonding, and beads were trapped in the opened-end reactor.
This work involves a simpler HA immobilization procedure via physical adsorption onto a glass capillary without any prior modification. The assay procedure is similar to that used for conventional micro-plate immunoassay, but with a much more convenient and less time-consuming automatic operation. The performance of the system is demonstrated by the assay of HA in human serum, and compared with a microplate-based assay format.
experimental

Reagents and chemicals
The preparations of a HA solution and biotinylated HA-binding proteins (b-HABPs) were as described in previous work. 8 To prepare many coated capillaries, off-line coating was done. Capillaries of 7.5 cm in length and 1.15 mm i.d. (micro-haematocrit tubes, BRIS) were filled with a HA solution. After sealing both ends with Parafilm ® , the capillaries were refrigerated (~8 C) overnight to allow for the maximum adsorption of HA onto the capillary wall.
The capillaries were washed with 10 mM phosphate buffer saline (PBS), pH 7.4, to remove any unbound HA. Then, a 1% w/v BSA (Sigma-Aldrich ® ) blocking reagent in a PBS solution was used to block any empty glass space that may not have been bound to HA. This was done to reduce any non-specific binding between the glass surface and other non-specific components, especially b-HABPs and anti-biotin conjugated with horseradish peroxidase (anti-b-HRP), which were later added.
Biotinylated HABPs powder, prepared using a method described by Rappuoli, 8, 28 was dissolved with 300 µl of a Tris-HCl buffer solution at pH 8.6. The solution of concentration 734.2 µg/ml was obtained. This stock solution was further diluted into a 1:100 ratio.
A stock standard HA solution, for competition with immobilized HA, was prepared by diluting 1 ml of standard HA (Hyalgan ® ) at the original concentration of 20 mg/2 ml (which is equivalent to 10 × 10 6 ng/ml) to a concentration of 10000 ng/ml with 6% BSA in a phosphate buffer.
The assay detection process was done through an enzyme-substrate reaction between anti-b-HRP (Zymed) and 3,3′,5,5′-tetramethylbenzidine (TMB, KPL).
Apparatus
The sequential injection (SI) system used for controlling the volume and the incubation time was virtually the same as that previously reported for the assay of sialoglycoconjugates. 22 It was composed of a bidirectional syringe pump with a 2.5-ml barrel (CARVO Scientific Instrument) controlled by computer software (FIAlab 3000, FIA Instrument), a 10-port selection valve (Valco Instrument), a spectrophotometer (Spectronic 21), and a personal computer. Figure 1 illustrates the positions of various reagents placed at the selection valve of the sequential injection-capillary immunoassay (SI-CI) system. The capillary was directly connected to one of the ports on the selection valve. Because TMB is light sensitive, it was kept in a dark-colored tube. Other reagents were kept in micro-centrifuge tubes and connected to the PTFE tubing (Upchurch) from the selection valve for delivery. The holding coil was Tygon tubing (Upchurch) which can hold 2.5 ml of solution.
The operational steps are basically similar to that for a normal bioassay of HA with a micro-plate format composed of many incubation and washing steps. However, the feature of a flow-based system where the reaction can be detected at any selected time without the need to wait for the maximum reaction at equilibrium makes each step much shorter than a batch-wise bioassay. The bidirectional syringe pump of the SI system ( Fig. 1 ) can draw zones of reagents/sample, one at a time, through each selected port of the multi-selection valve, and stack them in a holding coil before sending them to the capillary. Mixing takes place while the zones are flowing to the capillary via the designated port.
First, the citric phosphate buffer, pH 5.0, was sent to the detector to adjust the baseline. The computer software program was started. The capillary was washed with 1500 µl PBS. The mixed standard HA solution or serum sample and b-HABPs zone was made by drawing an air segment (20 µl) between the selection valve and the capillary, followed by a standard HA solution/serum sample (10 µl), b-HABPs (60 µl), and again a standard HA solution/serum sample (10 µl), and finally an air segment (20 µl). The air segments help to reduce any dispersion of the zone during reagent mixing and incubation. The standard HA solution or serum sample was on both sides of b-HABPs for better mixing. The zone was moved back and forth twice before sending to the capillary for incubation with the immobilized HA on the capillary. The unbound species were removed by discarding the zone to waste after incubation for 5 min. The capillary was washed with 2 ml of PBS. Then, anti-b-HRP (80 µl) with air segments on both sides (20 µl each) was drawn and sent into the capillary for incubation with b-HABPs. The unbound species were removed by discarding the zone to waste after incubation for 5 min. Again, the capillary was washed with 2 ml of PBS, followed by 2 ml of citric phosphate buffer. Then, substrate TMB (80 µl) was drawn and sent into the capillary with air segments on both sides (20 µl each) to incubate with anti-b-HRP for 7 min. A colored product of enzyme HRP and substrate TMB was produced. Finally, the product solution was drawn to the Spectronic 21 detector and the blue-color product was detected at 650 nm. To completely prevent an air bubble from entering the detection flow cell, the air segment was discarded to waste before sending the product to the detector. The discarded air volume (40 µl) needs to be higher than the aspirated air volume (20 µl) to ensure the complete removal of air. Therefore, the volume of the reaction zone being sent to the detector (50 µl) was lower than the aspirated TMB solution volume (80 µl). Figure 2 illustrates the competitive assay process for the determination of HA.
Serum samples
All collected blood samples were fasting blood. Serum samples of people with no evidence of bone or liver diseases (n = 15) were obtained from volunteers who gave their informed consent before participation in this study. 
Conventional micro-plate assay format
The results from the SI-CI system were compared with those from the conventional batch 96-well micro-plate assay method. The conventional method required 5 -8 h for the total analysis time. The procedure was as follows: first, the microtiter plate (Maxisorp ® , Nunc) was coated overnight at 4 C with 100 µl of an umbilical cord HA solution, and then the plate was washed with 350 µl of PBS before being blocked with 1% BSA at 25 C for 60 min. After that, the plate was washed with 350 µl of PBS. A mixture of 120 µl of the sample or standard HA and 120 µl b-HABPs was added and left to incubate at 25 C for 60 min. After the plate was washed with 350 µl of PBS, 100 µl of anti-b-HRP of a 1:1000 dilution ratio was added and allowed to incubate for 60 min at 25 C. The plate was washed again with 350 µl of PBS, and then 100 µl of the substrate TMB was added and incubated at 37 C for 20 min to allow the colored product to develop. The reaction was stopped by adding 50 µl of 4 M H2SO4. The product was detected at 429/690 nm with a micro-plate reader.
results and discussion
Optimization of the concentration and incubation time of various reagents
The concentration of various reagents were optimized to save reagents and to avoid unnecessary cost. The incubation times required for each step should be as short as possible to reduce the analysis time. Both the concentration and the incubation time affect the sensitivity of the analysis. Therefore, optimization was done to compromise with the sensitivity.
The concentrations of HA for capillary coating was varied in the range of 0, 10, 40, 80, 100 and 200 µg/ml. The signal increased with increasing the HA concentration up to 80 µg/ml. This indicated that the limited surface area of the capillary can accommodate HA up to this concentration. To ensure the excess amount of HA, 100 µg/ml was selected for further experiments.
The immobilization of HA onto a glass capillary wall via physical adsorption was compared at 37 and 8 C, because some bioassays have shown better efficiency of immobilization of some proteins onto a plastic micro-plate in an incubator, 29 while overnight incubation in the refrigerator may be more practical and convenient. It was found in this experiment that the immobilization of HA at 37 C for 5 h yielded approximately the same results as the immobilization of HA at 8 C for 24 h. However, the latter condition was chosen for convenience in capillary preparation scheduling.
The amount of b-HABPs is very important for the working range. An insufficient amount of b-HABPs for the competitive binding of immobilized HA and HA in the sample solution would result in a narrow working range, or an inability to differentiate various HA concentrations in samples. However, a too high amount of b-HABPs would lead to a high analysis cost. The dilution ratio of b-HABPs was varied from 0, 1:200, 1:100, 1:50 to 1:20. The signals obtained from a 1:100 dilution ratio were the same as those obtained using higher b-HABPs concentrations. Therefore, a 1:100 dilution ratio was selected.
In the SI-CI system, b-HABPs and a HA standard were introduced sequentially and mixed while flowing from a holding coil to the capillary (Figs. 1 and 2) . Immobilized HA and HA standards competed for limited binding sites of b-HABPs. The degree of interaction depended on the incubation time. A longer incubation time allows more diffusion of free b-HABPs to bind with immobilized HA. The optimum incubation time was investigated by stopping the mixture of b-HABPs and the HA standard in the HA-coated capillary for 0, 1, 3, 5, 7 and 9 min. Because the signals increased significantly with the increased incubation time up to 5 min, this incubation time was selected for further experiments. Signals leveled off at longer incubation times, which was likely due to the limited amount of immobilized HA.
After washing off unbound b-HABPs, anti-b-HRP was introduced to detect the amount of b-HABPs bound to the immobilized HA.
The binding between b-HABPs and anti-b-HRP was limited by the fixed amount of bound b-HABPs on the capillary. In correspondence to the highest possible bound amount of b-HABPs, i.e. no HA standard added for competitive binding, the concentration of anti-b-HRP at a 1:1000 dilution ratio was found to be most suitable among the varied concentrations of 1:3000, 1:2000, 1:1500, 1:1000 and 1:500 dilution ratios. A higher concentration (1:500), which offered the same signal, was avoided for unnecessary excessive washing to remove any unbound antibody.
Similarly, the longer incubation time should allow for better interactions between the bound b-HABPs and anti-b-HRP. The same incubation times as used in the previous step (0 -9 min) were tried. It was found that the signals were increased with the increased incubation time, but the signals were not significantly improved when the incubation time was longer than 5 min. Therefore, a 5 min incubation time was also selected for this step.
The last step involved an enzyme-substrate reaction. Better sensitivity would be obtained with the longest possible incubation time between the excess amount of the substrate TMB and the enzyme HRP. However, the sensitivity was limited by the available amount of HRP. The incubation time was varied from 0, 1, 3, 5, 7, 10 to 13 min. The signal was found to increase with a longer incubation time up to 7 min, and leveled off after this amount. Table 1 summarizes the selected conditions that are described above.
Stability of the HA coated capillary
The aim of this part of the study is to evaluate how long the HA-coated capillary, prepared as previously described, could be kept for later use. HA was immobilized onto the capillaries overnight, and after washing away the unbound HA the capillaries were divided into two groups. The first group of capillaries was filled with phosphate buffer (pH 7.4) and the second group was left dry. All capillaries were sealed with Parafilm on both ends prior to refrigeration at 8 C for 1, 3, 5, 7, and 14 days before use. The signals were compared with those obtained from the freshly prepared capillaries.
The capillaries filled with phosphate buffer could be kept for 3 days without any signal change. This indicated that the buffer solution may help to keep HA binding to the wall and to stabilize the HA conformation. The capillaries kept longer than 3 days showed a dramatic decrease of the signal. This may have been because the immobilization was done through physical adsorption, not covalent bonding. Therefore, the longer was the capillaries left in the buffer solution, the more HA could come off the wall back into the solution due to equilibrium. It was also found that the HA-coated capillaries could not be kept in only a dry condition. This may have been because HA was degraded, or its conformation was changed when left dry. To ensure the best results, all capillaries were freshly prepared.
Calibration curve
A calibration curve was constructed using various HA standard concentrations for competitive binding in the range of 1 -3000 ng/ml to cover the level of HA in serum found in a normal adult (estimated average level of 22.4 ng/ml 30 ), and various elevated levels found in liver and joint-disease patients. The profiles of analytical signals are shown in Fig. 3 and the corresponding calibration graph constructed from the peak area is shown in Fig. 4 .
The calibration curve was prepared by logistic fit using the Origin computer software Ver. 7.0. The sigmoid equation is
Here Y is the analytical signal (peak area), X the concentration of HA in ng/ml, A1 the initial Y value (30.12), A2 the final Y value (16.77), X0 the X value at Y equal to half of the limit A1 and A2 (80.42), respectively, and P the power (1.35).
The lowest detectable concentration was calculated to be 9 ng/ml (blank ± 2SD at 95% confidence). The working range was between 25 -500 ng/ml. The SD values shown in the high-concentration end of the calibration curve (100 -500 ng/ml, HA) were higher than that at other ranges. The narrow working range and the high SD in the end part of the calibration curve suggested that samples with a very high HA level should be diluted in order to have the signal fall into the calibration range with a low SD. However, the number of serum samples used in this study was rather small. For a more conclusive discussion, further study with a higher number of samples should be carried out.
In general, it was expected that the working range and the sensitivity of the capillary immunoassay-based system would not be as good as the bead-based immunoassay, as previously reported. 8 This is because of the limited surface area of a capillary, as compared to beads. However, the range obtained here is adequate to differentiate healthy people from patients. In addition, the elimination of back pressure and the possibility of applying a capillary immunoassay within a multi-analytes analysis system are benefits.
Precision
The within-run precision or repeatability was determined by analyzing a normal serum sample spiked with a 50 µl of 300 ng/ml standard HA under the selected operational condition. The analysis was performed repeatedly 10 times within one day. The relative standard deviation (RSD) was calculated to be 3.1%.
The between-run precision or reproducibility was determined similarly, but the analysis of a single sample was carried out repeatedly every day for 10 days. The relative standard deviation (RSD) was calculated to be 5.5%.
Application of the SI-CI system for the assay of HA in human serum
The performance of the automated sequential injection-capillary immunoassay (SI-CI) system that has been developed was demonstrated by the assay of HA in human serum samples. The results were compared with those obtained from the conventional micro-plate assay format. The average concentrations of HA in Table 1 Optimum concentrations of various reagents and incubation times for the assay of HA using the SI-CI system normal and liver-patient serum samples were compared as presented in Fig. 5 .
Comparisons of the HA level obtained from the SI-CI system and the conventional micro-plate assay in both normal-normal and patient-patient groups were made using the t-test. The comparisons are shown in Fig. 5 as dotted lines. A p-value of 2.25 × 10 -3 was found in a normal-normal group. This indicated that the level of HA in normal samples obtained from the two different systems (36 vs. 50 ng/ml) are significantly different at p < 0.01 (significant level 0.01 or 99% confidence level). On the other hand, the p-value of 8.12 × 10 -2 or p > 0.05 (significant level more than 0.05 or 95% confidence level) was found with the patient-patient group (320 vs. 264 ng/ml). This means that the levels of HA found in patients using the two different systems are not significantly different.
Even though, the SI-CI system gave results in normal subjects that differ from the conventional micro-plate method; this does not indicate any invalidity of the SI-CI system. It is more important that the SI-CI system can differentiate the normal group from the patients. Therefore, the comparisons of the HA concentrations in normal and the liver patient groups obtained from the SI-CI system and the conventional micro-plate assay format were also performed using the t-test (shown as solid lines). It was found that the levels of HA in the two sample groups were significantly different in both methods. The p-value from a comparison of the average HA levels in normal and patient groups of 1.94 × 10 -5 or p < 0.001 (significant level 0.001 or 99.9% confidence level) was found when using the SI-CI system (50 vs. 264 ng/ml) and the p-value of 8.68 × 10 -7 or p < 0.001 (significant level 0.001 or 99.9% confidence level) was found when using the micro-plate assay (36 vs. 320 ng/ml).
In other words, both assay formats could differentiate the normal group from the liver patient group.
Conclusions
As a part in developing an automation system for multi-biomarkers analysis, a sequential injection-capillary immunoassay (SI-CI) system using a low-cost glass capillary instead of a fused silica capillary was applied to assay HA, another biomarker in addition to sialoglycoconjugates. The SI stand-alone system can distinguish the average concentration of HA found in normal and patient groups with the benefits over the conventional micro-plate assay method in terms of the analysis time per run (20 min vs. 5 h) and the amount of reagent and the sample consumption (10 -80 µl vs. 100 -350 µl). However, the conventional micro-plate assay format can accommodate many samples in parallel. Therefore, it is more useful for a large number of samples, while the SI-CI is suitable for a low-to-medium number of samples, where fast results are needed. In addition, the automatic feature of the SI-CI system also diminishes the requirement of having a well-trained medical operator, which would be useful for places where the number of medical personnel is inadequate. An automatic system that cuts down on the difficulty of operating a multi-step manual assay like this one, has a potential to be used in a future "telemedicine" system. Nevertheless, several points still need to be explored, for example, determining a suitable way to keep the coated capillaries for further use, and running more samples to determine the cut-off value that distinguishes the normal and patient groups. , normal serum samples obtained from SI-CI; ×, liver patient serum samples obtained from SI-CI.
